genOway Société anonyme (ALGEN.PA)

EUR 3.92

(0.0%)

Operating Income Summary of genOway Société anonyme

  • genOway Société anonyme's latest annual operating income in 2023 was 2.06 Million EUR , up 192.14% from previous year.
  • genOway Société anonyme's latest quarterly operating income in 2024 Q2 was 697 Thousand EUR , down 0.0% from previous quarter.
  • genOway Société anonyme reported an annual operating income of -2.24 Million EUR in 2022, up 51.23% from previous year.
  • genOway Société anonyme reported an annual operating income of -4.59 Million EUR in 2021, down -19.7% from previous year.
  • genOway Société anonyme reported a quarterly operating income of 2.06 Million EUR for 2023 FY, up 192.14% from previous quarter.
  • genOway Société anonyme reported a quarterly operating income of -898.09 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of genOway Société anonyme (2023 - 2009)

Historical Annual Operating Income of genOway Société anonyme (2023 - 2009)

Year Operating Income Operating Income Growth
2023 2.06 Million EUR 192.14%
2022 -2.24 Million EUR 51.23%
2021 -4.59 Million EUR -19.7%
2020 -3.83 Million EUR -567.44%
2019 -575.13 Thousand EUR -199.2%
2018 579.8 Thousand EUR -23.08%
2017 753.77 Thousand EUR 8.94%
2016 691.9 Thousand EUR 81.31%
2015 381.61 Thousand EUR 51.67%
2014 251.6 Thousand EUR 44.91%
2013 173.62 Thousand EUR 139.48%
2012 -439.76 Thousand EUR -222.35%
2011 359.41 Thousand EUR -49.63%
2010 713.58 Thousand EUR 89.58%
2009 376.39 Thousand EUR 0.0%

Peer Operating Income Comparison of genOway Société anonyme

Name Operating Income Operating Income Difference
ABIONYX Pharma SA -3.41 Million EUR 160.53%
ABIVAX Société Anonyme -127.37 Million EUR 101.621%
Adocia SA -17.62 Million EUR 111.72%
Aelis Farma SA -6.46 Million EUR 131.966%
Biophytis S.A. -14.33 Million EUR 114.409%
Advicenne S.A. -6.45 Million EUR 131.985%
IntegraGen SA -183.77 Thousand EUR 1223.848%
Medesis Pharma S.A. -4.22 Million EUR 148.833%
Neovacs S.A. -6.9 Million EUR 129.899%
NFL Biosciences SA -4.43 Million EUR 146.616%
Plant Advanced Technologies SA -778.23 Thousand EUR 365.381%
Quantum Genomics Société Anonyme -3.13 Million EUR 165.831%
Sensorion SA -22.31 Million EUR 109.257%
Theranexus Société Anonyme -7.64 Million EUR 127.02%
TME Pharma N.V. -5.62 Million EUR 136.723%
Valbiotis SA -7.16 Million EUR 128.845%
TheraVet SA -2.17 Million EUR 194.951%
Valerio Therapeutics Société anonyme -20.28 Million EUR 110.18%
argenx SE -417.15 Million EUR 100.495%
BioSenic S.A. -7.04 Million EUR 129.337%
Celyad Oncology SA -8.45 Million EUR 124.421%
DBV Technologies S.A. -85.24 Million EUR 102.423%
Galapagos NV -88.26 Million EUR 102.34%
Genfit S.A. -26.58 Million EUR 107.77%
GeNeuro SA -14.35 Million EUR 114.385%
Hyloris Pharmaceuticals SA -15.99 Million EUR 112.914%
Innate Pharma S.A. -12.66 Million EUR 116.302%
Inventiva S.A. -102.7 Million EUR 102.011%
MaaT Pharma SA -19.94 Million EUR 110.356%
MedinCell S.A. -20.97 Million EUR 109.846%
Nanobiotix S.A. -26.77 Million EUR 107.712%
Onward Medical N.V. -35.46 Million EUR 105.824%
Oryzon Genomics S.A. -4.54 Million EUR 145.399%
OSE Immunotherapeutics SA -22.98 Million EUR 108.985%
Oxurion NV -12.11 Million EUR 117.054%
Pharming Group N.V. -4.87 Million EUR 142.326%
Poxel S.A. -28.76 Million EUR 107.18%
GenSight Biologics S.A. -29.69 Million EUR 106.955%
Transgene SA -30.01 Million EUR 106.882%
Financière de Tubize SA -2.14 Million EUR 196.33%
UCB SA 604 Million EUR 99.658%
Valneva SE -82.08 Million EUR 102.516%
Vivoryon Therapeutics N.V. -28.83 Million EUR 107.162%